Brief: Immunovia Q3 Net Loss Widens To SEK 38.6 Mln
Nov 9 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA PUBLISHES INTERIM REPORT FOR JANUARY-SEPTEMBER
2023
* Q3 NET SALES AMOUNTED TO KSEK 488 (358)
* Q3 NET EARNINGS WERE MSEK -38.6 (-22.9)
* EXPLORING STRATEGIC PARTNERSHIPS THAT WILL ALLOW US TO
SUCCEED
IN 2024 AND BEYOND
Source text for Eikon: ID:nPn8NQDysa
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study